Slaoui Moncef 4
4 · Intellia Therapeutics, Inc. · Filed Jul 25, 2017
Insider Transaction Report
Form 4
Slaoui Moncef
Director
Transactions
- Award
Stock Option (right to buy)
2017-07-25+38,000→ 38,000 totalExercise: $16.91Exp: 2027-07-24→ Common Stock (38,000 underlying)
Footnotes (1)
- [F1]This option was granted on July 25, 2017 with respect to 38,000 shares of Common Stock, with 33% vesting on July 25, 2018 and the remaining 67% vesting in eight substantially equal quarterly installments thereafter.